Development, Characterization and Evaluation of Lactoferrin Conjugated and Memantine Loaded Peg-Plga Nanoparticles for the Treatment of Alzheimer's Disease

References (23)

1. 1 Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery [DOI]
2. 2 Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization [DOI]
3. 3 Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis [DOI]
4. 4 Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease [DOI]
5. 5 Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice [DOI]
6. 6 Nanoparticles for Targeted Brain Drug Delivery: What Do We Know? [DOI]
7. 7 Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease [DOI]
8. 8 W/O/W double emulsion technique using ethyl acetate as organic solvent: effects of its diffusion rate on the characteristics of microparticles [DOI]
9. 9 Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases [DOI]
10. 10 Surface modified PLGA nanoparticles for brain targeting of Bacoside-A [DOI]
11. 11 Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer’s Disease in Mice [DOI]
12. 12 Effect of PLGA NP size on efficiency to target traumatic brain injury [DOI]
13. 13 Systemic delivery to central nervous system by engineered PLGA nanoparticles.
14. 14 SYNTHESIS AND CHARACTERIZATION OF LIGAND ANCHORED POLY PROPYLENEIMINEDENDRIMERS FOR THE TREATMENT OF BRAIN GLIOMA [DOI]
15. 15 Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model [DOI]
16. 16 New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9 [DOI]
17. 17 Design of Nanosuspensions and Freeze-Dried PLGA Nanoparticles as a Novel Approach for Ophthalmic Delivery of Pranoprofen [DOI]
18. 18 Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine [DOI]
19. 19 Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: Ocular anti-inflammatory applications [DOI]
20. 20 Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan [DOI]
21. 21 SYNTHESIS AND CHARACTERIZATION OF TEMOZOLOMIDE LOADED THERANOSTIC QUANTUM DOTS FOR THE TREATMENT OF BRAIN GLIOMA [DOI]
22. 22 Efficacy of memantine hydrochloride once-daily in Alzheimer’s disease [DOI]
23. 23 A Review on Novel Techniques for Drug Delivery to the Brain

Cited by 18

Showing 6 of 18 known citations — external sources report more than can currently be individually listed.

Related research

• Anti-Acetylcholinesterase Activity of Commercially Important Ceylon Black Tea (Camellia sinensis L.) Grades Belonging to Different Elevations: Potential Natural Product for Type 3 Diabetes Management? — shares topic coverage
• Evaluation of Antioxidant and Cholinesterase Inhibitory Activities of Hoya parasitica Variegata - An In-vitro Study — shares topic coverage
• From Oral Hygiene to Cognitive Health: Examining the Relationship between Periodontal Disease and Alzheimer's — shares topic coverage
• Emotional Repercussion and Changes Experienced by Family Caregivers of Individuals with Alzheimer's: A Study in the Southern Region of Tocantins, Brazil — shares topic coverage
• Exploring the Role of Cannabis in Modulating Pathological Mechanisms of Alzheimer's Disease — shares topic coverage